The Aβ pathology also plays a central role in late-onset AD, where the dosage of the apolipoprotein E (APOE) epsilon 4 allele was identified as a major AD risk factor that impacts Aβ uptake and clearance [4]. Here, APOE is linked to Alzheimer disease.